CONÓCENOS 2026
Making Pharma Spain: Barcelona, ES | 18-19 Feb 2026
|
PharmaForum: Mainz, DE | 05 Mar 2026
|
KOREA PHARM & BIO: Seoul, KR | 31 Mar – 03 Apr 2026
|
Cell & Gene Meeting on the Med: Rome, IT | 28-30 Apr 2026
|
BIO KOREA 2026: Seoul, KR | 28-30 Apr 2026
|
Swiss Biotech Days: Basel, CH | 04-05 May 2026
|
Partnering Day Mabdesign: Lyon, FR | 12 May 2026
|
ICGT Congress: Gentilly, FR | 27-28 May 2026
|
Simposio AFI: Rimini, IT | 10-12 Jun 2026
|
Antibody Industrial Symposium: Montpellier, FR | 30 Jun – 01 Jul 2026
|
BIO Asia-Taiwan Exhibition: Taipei, TW | 16-19 Jul 2026
|
CPHI 2026: Milan, IT | 06-08 Oct 2026
logo-dark

Digital Marketing

About Sandra Magdaleno

This author has not yet filled in any details.
So far Sandra Magdaleno has created 28 blog entries.

Desarrollo de biosimilares: de la fase III a la comparabilidad analítica y farmacocinética/farmacodinámica.

Aunque el desarrollo de biosimilares ha sido históricamente difícil, costoso [...]

By |2025-11-07T11:07:59+01:007. noviembre 2025|Bioanálisis, CMC|Comentarios desactivados en Desarrollo de biosimilares: de la fase III a la comparabilidad analítica y farmacocinética/farmacodinámica.
Go to Top